76 / 100

Dr. guanglin Zhang | Nanomedicine | Best Researcher Award

Lecturer, Shaoguan University, China

Dr. Guanglin Zhang is a dedicated Lecturer at Shaoguan University, specializing in the study of inflammatory diseases and tissue repair. Holding a PhD in his field, Dr. Zhang’s research focuses on the function and regulatory mechanisms of macrophages, plant-derived extracellular vesicles, and immunomodulatory implants. He aims to develop therapeutic strategies for immune regulation and tissue regeneration, contributing significantly to both academic and practical applications. His work has led to multiple publications in high-impact journals, advancing knowledge in nanomedicine and biomedical materials. Dr. Zhang is actively involved in the academic community and strives to translate his findings into real-world healthcare improvements. 🌿📚

Publication Profile

Scopus

Education

Dr. Zhang holds a PhD in his field, emphasizing macrophage function and tissue repair mechanisms. His academic journey has been centered around studying and applying biomaterials for therapeutic applications, contributing to various research projects that improve human health. His education laid the foundation for his focus on immunology, tissue regeneration, and nanomedicine. 🎓🔬

Experience

Currently a Lecturer at Shaoguan University, Dr. Zhang has spent years researching and teaching in the areas of nanomedicine and biomedical materials. His previous experience includes leading projects aimed at exploring macrophage polarization and engineering extracellular vesicles for therapeutic purposes. His roles have spanned from researcher to educator, and he continues to influence the field through his work. 🧑‍🏫💼

Awards and Honors

While Dr. Zhang does not have any major awards listed at the moment, his research contributions have been acknowledged through numerous published works in reputable journals. His continued work in macrophage-related therapies and nanomedicine positions him as an emerging leader in his field. 🏅🔖

Research Focus

Dr. Zhang’s research is centered on nanomedicine, biomedical materials, and inflammatory diseases. He has focused on developing apoptotic cell-derived extracellular vesicles, biomimetic materials, and immunomodulatory implants to advance therapeutic strategies. His studies aim to promote anti-inflammatory effects and tissue regeneration, offering potential treatments for diseases involving immune dysregulation. 🧬💡

Conclusion

Dr. Zhang is an accomplished and promising researcher in the field of biomaterials and nanomedicine. His work on macrophage regulation and therapeutic vesicles continues to advance the frontiers of tissue repair and inflammation treatment. As a lecturer and researcher, he is dedicated to advancing knowledge and contributing to healthcare solutions, ensuring his work has a lasting impact in the field. 🌟👨‍🔬

Publications 

A low-modulus phosphatidylserine-exposing microvesicle alleviates skin inflammation via persistent blockade of M1 macrophage polarization

Phosphatidylserine-functional polydimethylsiloxane substrates regulate macrophage M2 polarization via modulus-dependent NF-κB/PPARγ pathway

Soft apoptotic-cell-inspired nanoparticles persistently bind to macrophage membranes and promote anti-inflammatory and pro-healing effects

Pulmonary delivery of therapeutic proteins based on zwitterionic chitosan-based nanocarriers for treatment on bleomycin-induced pulmonary fibrosis

How BMP-2 induces EMT and breast cancer stemness through Rb and CD44

Softness enhanced macrophage-mediated therapy of inhaled apoptotic-cell-inspired nanosystems for acute lung injury

Improved tribological properties, cyto-biocompatibility and anti-inflammatory ability of additive manufactured Ti-6Al-4V alloy through surface texturing and nitriding

A zwitterionic serine modified chitosan derivative for improving protein stability and activity

FGF-7 facilitates the process of psoriasis by inducing TNF-α expression in HaCaT cells

BMP-2 induces EMT and breast cancer stemness through Rb and CD44

Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtype of FGFRs: implications for anticancer activity

 

guanglin Zhang | Nanomedicine | Best Researcher Award

You May Also Like